Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
06/2002
06/05/2002EP0915836B1 Materials with ferromagnetic properties comprising organic molecules with magnetic properties, and methods for making same
06/05/2002EP0629199B1 Indole derivatives as 5-ht1 agonists
06/05/2002CN1352632A N-substituted-N'-substituted urea derivative and use thereof as TNF-Alpha production inhibitor
06/05/2002CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists
06/05/2002CN1085979C Inhibitor for narcotic analgetic dependence/resistance aquisition
06/04/2002USRE37729 Useful as antipsychotic and analgesic agents.
06/04/2002US6399824 For therapy and prophylaxis of arrhythmias, cardiac infraction, ischemic conditions, angina pectoris, shock, for preserving and storing a transplant for surgical measure
06/04/2002US6399771 Cyclic imines as pesticides
06/04/2002US6399650 Improving the disturbances of the activities of daily living (adl) in a post-stroke patients comprises administering to the patient an effective amount of nefiracetam within the first six months after the stroke
06/04/2002US6399635 N,n-diethyl-4-(n-piperidin-3-yl-anilino) benzamide compound; reductive amination of a 3-piperidone, arylation
06/04/2002US6399629 Efflux pump inhibitors
05/2002
05/30/2002WO2002042414A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
05/30/2002WO2002042273A2 Acid derivatives useful as serine protease inhibitors
05/30/2002WO2002042271A2 Biphenylcarboxamides useful as lipid lowering agents
05/30/2002WO2002042268A2 Ep4 receptor selective agonists in the treatment of osteoporosis
05/30/2002WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
05/30/2002WO2002041984A2 Catalytic compositions and methods for asymmetric aldol reactions
05/30/2002WO2002041834A2 Atorvastatin hemi-calcium form vii
05/30/2002WO2002020526A3 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
05/30/2002WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
05/30/2002WO2001064646A3 Hydrazones and analogs as cholesterol lowering agents
05/30/2002WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
05/30/2002US20020065422 Fluorescent maleimides and uses thereof
05/30/2002US20020065417 Useful as ligands for metal catalysts for asymmetric reactions, in particular as rhodium complexes for asymmetric hydrogenation of enamide, itaconate, and alpha-ketoester compounds
05/30/2002US20020065315 For therapy and prophylaxis of asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, etc.
05/30/2002US20020065308 EP4 receptor selective agonists in the treatment of osteoporosis
05/30/2002US20020065302 Cyclic AMP-specific phosphodiesterase inhibitors
05/30/2002US20020065278 Non-imidazole aryloxyalkylamines
05/30/2002US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives
05/30/2002US20020065192 Productivity catalysts and microstructure control
05/30/2002CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002CA2428191A1 Acid derivatives useful as serine protease inhibitors
05/29/2002EP1209147A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
05/29/2002EP1208091A1 Benzophenones as inhibitors of reverse transcriptase
05/29/2002EP1207882A1 Acyclic and cyclic amine derivatives
05/29/2002EP0863872B1 Preparation of chiral 3-hydroxy-2-pyrrolidinone derivatives
05/29/2002CN1351598A Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
05/29/2002CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof
05/29/2002CN1351493A Process for the production of amorphous atorvastatin calcium
05/29/2002CN1351492A synergistic effects of amlodipine and atorvastatin
05/28/2002US6395911 Process for cis-1{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy] ethyl}pyrrolidine
05/28/2002US6395759 Psychological disorders
05/28/2002US6395758 Small molecule carbamates or ureas for vision and memory disorders
05/28/2002US6395757 Method for treating hot flashes in humans
05/28/2002US6395735 An indane-like compounds which can be useful for treating psychosis and other conditions associated with modulation of a muscarinic receptor
05/28/2002US6395731 Anticoagulants
05/28/2002US6395724 Multibinding inhibitors of cyclooxygenase-2
05/28/2002US6395683 Heterocyclylbenzonitriles
05/28/2002US6395367 Electroconductivity
05/28/2002US6395282 Carrier molecule conjugated to specific autoinducers; vaccines for the treatment and prevention of infection
05/23/2002WO2002040461A2 Aminoalkoxybiphenyl carboxamides as histamine-3 receptor ligands and their therapeutic applications
05/23/2002WO2002040154A1 Catalysts comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalysts
05/23/2002WO2001083571A3 Catalysts containing n-pyrrolyl substituted nitrogen donors
05/23/2002US20020062033 Intermediates of aromatic amidine derivatives which have anticoagulation action
05/23/2002US20020062032 Crystalline forms of antibiotic side chain intermediates
05/23/2002US20020062012 Novel azoamidine compound
05/23/2002US20020062004 Enantioselective hydrogenation
05/23/2002US20020061923 Diacid isoindoleine amide derivative
05/23/2002US20020061916 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
05/23/2002US20020061911 Enantiomers of 6-amino EM-12 and method of use
05/23/2002US20020061898 Inhibitors of nucleoside metabolism
05/23/2002US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis
05/23/2002US20020061881 Compounds, compositions, and methods for stimulating neuronal growth and elongation
05/23/2002US20020061877 Substituted cyclic amine metalloprotease inhibitors
05/22/2002EP1206484A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
05/22/2002EP1206470A2 Processes and intermediates for the preparation of isoxazolecarboxamides and analogues
05/22/2002EP1206450A1 Synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
05/22/2002EP1206446A1 Carboxylic acid amides, their production and their use as drugs
05/22/2002EP1206444A1 Compounds that inhibit tryptase activity
05/22/2002EP1206442A1 Substituted chiral allosteric hemoglobin modifiers
05/22/2002CN1350530A 酰胺衍生物 Amide derivatives
05/22/2002CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
05/22/2002CN1349796A Pyrrole derivatives and medicine composition
05/21/2002US6392103 Using organometallic compound as catalyst
05/21/2002US6392046 Aids therapy
05/21/2002US6391910 Opioid antagonist; analgesic
05/21/2002US6391909 Anandamide inhibitors as analgesic agents
05/21/2002US6391892 Naphthyl pharmaceutical compounds
05/21/2002US6391889 Potent antimicrobial activity on broad range of microorganisms, e.g., staphylococcus, grampositive bacteria and quinolone antibiotic resistance; side effect reduction; nontoxic
05/21/2002US6391877 Eating disorders; sexual disorders; antidepressants; antiepileptic agents
05/21/2002US6391827 Pyrrolic compounds having a high herbicidal activity and their agronomic use
05/16/2002WO2002038542A1 Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses
05/16/2002WO2002038541A1 Cyanopyrrolidine derivatives
05/16/2002WO2002038120A1 Photo-labile pro-fragrance conjugates
05/16/2002WO2002037937A2 Acid derivatives useful as serine protease inhibitors
05/16/2002WO2002030891A8 Aliphatic nitrogenous five-membered ring compounds
05/16/2002WO2002030890A8 Nitrogenous five-membered ring compounds
05/16/2002WO2002026697A3 Aromatic derivatives with hiv integrase inhibitory properties
05/16/2002WO2001097790A3 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
05/16/2002WO2001096295A3 2-cyanopyrrolidine derivatives and their use as medicaments
05/16/2002WO2001085144A3 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
05/16/2002US20020058811 Naphthalene derivatives
05/16/2002US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis
05/16/2002US20020058710 For therapy and prophylaxis of arrhythmias, cardiac infraction, ischemic conditions, angina pectoris, shock, for preserving and storing a transplant for surgical measure
05/16/2002US20020056827 Piezoelectric element and process for production thereof
05/16/2002DE10053795A1 5-HT6 Receptor antagonist medicaments, useful for treating central nervous system disorders such as Alzheimer's disease, comprising naphthalene N-phenylsulfonamide derivatives
05/16/2002CA2512476A1 Cyanopyrrolidine derivatives
05/16/2002CA2426716A1 Acid derivatives useful as serine protease inhibitors
05/16/2002CA2426033A1 Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses